Transfusion and Haematology Today - Issue 3/2013
Comprehensive Reports, Original Papers, Case Reports
125
Initial experience of Czech MDS Group with 5-azacytidine in patients with high risk myelodysplastic syndromes (IPSS intermediate II and high), acute myeloid leukaemia with less than 30% myeloblasts and chronic myelomonocytic leukaemia II
A. Jonášová, J. Čermák, L. Červinek, L. Nováková, P. Bělohlávková, J. Vondráková, O. Černá, M. Sýkora, N. Seifertová, L. Walterová, J. Libiger, I. Hochová, J. Ullrychová, P. Rohoň, J. Obernauerová, M. Schutzova, V. Vozobulová, H. Poláčková, K. Kačmářová, J. Mužík
134
The importance of serum immunoglobulin free light chain assay in AL amyloidosis
T. Pika, P. Lochman, J. Minařík, J. Bačovský, V. Ščudla
140
Lymphomas of gastrointestinal tract – clinico-pathological review
A. Janíková, I. Zambo, A. Baumeisterová, M. Hermanová, J. Mayer
152
Plasma cell leukaemia
T. Jelínek, H. Plonková, R. Hájek
163
Current treatment of myelofibrosis based on risk stratification of patients
M. Palová, K. Indrák, A. Hluší, T. Szotkowski
171
Acquired thrombophilias as a cause of early pregnancy losses
M. Simonidesová, J. Šimko, M. Martišová, K. Holomáň
180
Microbiological control for processing of blood
M. Czirfuszová, D. Matušová, M. Širicová
Transfusion and Haematology Today
2013 Issue 3
Most read in this issue
- Current treatment of myelofibrosis based on risk stratification of patients
- Lymphomas of gastrointestinal tract – clinico-pathological review
- Plasma cell leukaemia
- The importance of serum immunoglobulin free light chain assay in AL amyloidosis